Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > EV / EBITDA (ntm)

Aerie Pharmaceuticals EV / EBITDA (ntm) Chart (AERI)

Aerie Pharmaceuticals annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Aerie Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $2,142m a 11.86% increase of 254m year over year
  • Aerie Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 14.78 a -42.15% decrease of -6.23 year over year
  • Aerie Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $2,017m a 10.53% increase of 212m year over year
View Chart On Koyfin